Funded Tech Companies
Tarsa Therapeutics
Operating out of Philadelphia, Tarsa Therapeutics has funding from private investors, Oxford Finance and Square 1 Bank.
Company Overview
Company Name
Tarsa Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
8 Penn Center 1628 John F. Kennedy Blvd. 1400
Philadelphia, PA 19103
USA
Philadelphia, PA 19103
USA
Phone
Website
Email Address
Company Background Information
Overview
Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/26/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Brand
Chief Medical Officer
David Krause
Chief Scientific Officer
James Gilligan
VP - Regulatory Affairs
Nicholas LaBella
Company Investors
- Oxford Finance
- Square 1 Bank
- Quaker Partners
- Novo Ventures (Martin Edwards)
- Foresite Capital (James Tananbaum)
- Quaker Partners (Matthew Rieke)
- Quaker Partners (Sanjay Mistry)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs